Ryner Lai, MBBS

Ryner Lai, MBBS

Dr Ryner Lai (MBBS) is a medical graduate from Queen Mary, University of London. He is a medical writer who is passionate about the power of medical research to transform the lives of patients.

All articles by Ryner Lai, MBBS


Ankle Joint Fusion Is a Viable Treatment Approach in Hemophilic Ankle Arthropathy

Ankle arthrodesis performed in patients with hemophilic ankle arthropathy may improve pain and functioning while keeping revision and complication rates low, according to a study published in Haemophilia.  The authors conducted a literature review to investigate the mid- to long-term postoperative outcomes of ankle joint fusion in patients with hemophilia. They sought to understand the…

doctors laboratory

Trial to Assess Fecal Transplantation for Nintedanib-Induced Diarrhea in IPF

Researchers will soon start recruiting for a clinical trial that will examine the use of fecal microbiota transplantation to offer symptomatic relief for diarrhea induced by nintedanib in patients with idiopathic pulmonary fibrosis (IPF).  This interventional trial intends to enroll 114 participants, and double blinding will be applied. All participants must be adults diagnosed with…

liver transplant

Pediatric Patient With AATD Undergoes Liver Transplantation From a Heterozygous Donor

A boy with alpha-1 antitrypsin deficiency (AATD) underwent a liver transplantation from a heterozygous donor, researchers reported in Pediatric Transplantation.  The 9-year-old boy was diagnosed with AATD (ZZ phenotype) at 4 months of age. At that time, he presented with hepatomegaly and was treated with ursodeoxycholic acid and offered supportive care. At 7 years of…

Coca plant

More Than 1000 Plant Species Have Potential in Treating Neurodegenerative Disorders

There are more than 1000 plant species that may have therapeutic relevance in tackling neurodegenerative diseases such as Friedreich ataxia, spinal muscular atrophy, and multiple sclerosis, according to a study published in IBRO Neuroscience Reports. While significant pharmacological progress has been made for certain diseases (such as those involving the cardiopulmonary system), effective therapies tackling…

Right ventricle-highlighted heart

Aggressive Afterload Lowering as a Strategy to Improve PAH Outcomes

Despite improvements in our understanding of the pathophysiology of pulmonary arterial hypertension (PAH), it remains a disease of significant morbidity and mortality.  PAH is characterized by dyspnea/fatigue, a common presentation among patients with heart failure. A diagnosis of PAH can only be made when other cardiac/pulmonary causes of increased pulmonary arterial pressure have been ruled…

Next post in ALGS Insights